Status:
COMPLETED
Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)
Lead Sponsor:
Khon Kaen University
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Clozapine treatment resistant schizophrenia is still prevalent.The effectiveness of augmenting clozapine : one augmenting with haloperidol and the other with electroconvulsive therapy should be determ...
Eligibility Criteria
Inclusion
- schizophrenic patients diagnosed with schedules for clinical assessment in neuropsychiatry ( SCAN )in accordance with DSM-IV-TR or ICD-10
- Resistant to at least 6 weeks of clozapine treatment in therapeutic dosage
- Voluntary to participate the research protocol expressed by signing informed consent form
Exclusion
- Patient does not volunteer himself or herself
- Patient is having epilepsy, DM, cardiac disease, autistic disorder and illiterate
- Patient is deaf, blind , dumb to obstruct good communication
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00753051
Start Date
June 1 2008
End Date
May 1 2012
Last Update
May 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry.Faculty of Medicine.KhonKaen University.
Muang, KhonKaen, Thailand, 40002